Epstein Secrets

kibi Foundation President Iyad el-Baghdadi, New York Times Beirut Bureau Chief Ben Hubbard, Middle East Center Visiting Professor Madawi Al-Rasheed, American Enterprise Institute Resident Scholar Karen Young, Carnegie Endowment for International Peace Visiting Fellow Yasmine Farouk, Soufan Group Chairman and CEO Ali Soufan,

• Birx Seeks To Reassure Americans Of Vaccine Safety. • Modema Says Its Vaccine Won't Be Ready Until Spring 2021. • FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. • White House Rejected CDC's Request For Cruise Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedure

ibi Foundation President Iyad el-Baghdadi, New York Times Beirut Bureau Chief Ben Hubbard, Middle East Center Visiting Professor Madawi Al-Rasheed, American Enterprise Institute Resident Scholar Karen Young, Carnegie Endowment for International Peace Visiting Fellow Yasmine Farouk, Soufan Group Chairman and CEO Ali Soufan,

• Birx Seeks To Reassure Americans Of Vaccine Safety. • Moderna Says Its Vaccine Won't Be Ready Until Spring 2021. • FDA Broadens Investigation Of AstraZeneca's Coronavirus Vaccine Trial. • White House Rejected CDC's Request For Cruise Ship Ban Extension. • CDC Report On Meatpacking Plant Safety Procedure

Council Senior Director for Energy and Climate Change John Morton; SAIS Assistant Professor of Energy, Resources, and Environment Dr Jonas Nahm; and American Enterprise Institute Resident Scholar Dr Dalibor Rohac; 10:00 AM * House Commerce subcommittee remote hearing on the ACA and coronavirus — Health Subcommittee remote h

fore reaching the final goal of 164." Modema won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro

rm-effects-of-covid-still- unknown> (11/23, Weixel, 2.98M) reports former Food and Drug Administration commissioner Scott Gottlieb spoke Monday at a American Enterprise Institute panel discussion, where he warned that medical community does not have enough data to understand the long-term medical impacts of COVID-19. He "said

crat On Senate Judiciary Committee. • House Democrats Prepare To Govern With Tightest Majority in Two Decades. International News EFTA00137296 • AstraZeneca-Oxford Coronavirus Vaccine Data Indicates Shot Is Up To 90% Effective. • European Governments Prepare To Ease Lockdowns For December Holidays. • UK

Technology Enterprise; with testimony from former Acting Deputy Secretary of Defense Christine Fox; former DARPA Director Dr Victoria Coleman; and American Enterprise Institute Resident Fellow Klon Kitchen * Held via WebEx and in Rm 2118, Rayburn House Office Building; 11:00 AM • House Infrastructure subcommittee hybrid h

2/22, Jamison, 10.52M) reports that in Baltimore, Emergent BioSolutions "is manufacturing almost all of the yet-to-be approved Johnson & Johnson and AstraZeneca coronavirus vaccines for the U.S. population - an anticipated hundreds of millions of doses in the coming months." But "in a sign of the complexiti

Long-Term COVID Effects. The Hill (11/23, Weixel, 2.98M) reports former Food and Drug Administration commissioner Scott Gottlieb spoke Monday at a American Enterprise Institute panel discussion, where he warned that medical community does not have enough data to understand the long-term medical impacts of COVID-19. He "sai

Secretary of Health and Human Services tells our Bob Woodward both Moderna and Pfizer, 40 million doses will be from those companies, and that the AstraZeneca news is obviously very promising. He also points out it's being made right here in the US, so once it's approved...it will be ready." The Washingto